Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal.Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a $10.5…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
